These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18562435)

  • 1. Does oral alprazolam affect ventilation? A randomised, double-blind, placebo-controlled trial.
    Carraro GE; Russi EW; Buechi S; Bloch KE
    J Psychopharmacol; 2009 May; 23(3):322-7. PubMed ID: 18562435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring.
    Riba J; Rodríguez-Fornells A; Münte TF; Barbanoj MJ
    Brain Res Cogn Brain Res; 2005 Oct; 25(2):554-65. PubMed ID: 16168630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cognitive effect of alprazolam in healthy volunteers].
    Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
    Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers.
    Thai D; Dyer JE; Jacob P; Haller CA
    Clin Pharmacol Ther; 2007 Feb; 81(2):178-84. PubMed ID: 17192771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone--a double-blind randomized study.
    Forster A; Morel D; Bachmann M; Gemperle M
    Anesth Analg; 1983 Oct; 62(10):920-4. PubMed ID: 6137171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.
    Bertz RJ; Kroboth PD; Kroboth FJ; Reynolds IJ; Salek F; Wright CE; Smith RB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1317-29. PubMed ID: 9190868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans.
    Lu K; Gray MA; Oliver C; Liley DT; Harrison BJ; Bartholomeusz CF; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2004 Oct; 19(7):457-65. PubMed ID: 15378679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of diazepam with quantitative EEGs taken with eyes opened and topography].
    Yamadera H; Kato M; Ueno T; Suzuki H; Nakamura S; Okuma T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):137-41. PubMed ID: 9278939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive indices of autonomic regulation after alprazolam and lorazepam: effects on sympathovagal balance.
    Tulen JH; Man in't Veld AJ
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):183-90. PubMed ID: 9700978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
    Wettstein JG; Teeple ES; Morse WH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1328-34. PubMed ID: 1979816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen breathing and ventilation.
    Marczak M; Pokorski M
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):127-34. PubMed ID: 15082873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge.
    Poma SZ; Merlo-Pich E; Bettica P; Bani M; Fina P; Ziviani L; Milleri S
    J Psychopharmacol; 2014 May; 28(5):491-7. PubMed ID: 24108409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic response profiles of anxiolytic and sedative drugs.
    Chen X; Broeyer F; de Kam M; Baas J; Cohen A; van Gerven J
    Br J Clin Pharmacol; 2017 May; 83(5):1028-1038. PubMed ID: 27922194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.
    Semlitsch HV; Anderer P; Saletu B
    Eur J Clin Pharmacol; 1995; 49(3):183-91. PubMed ID: 8665994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.